Litcius/Paper detail

Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis

Pablo Demelo‐Rodríguez, Ana Isabel Farfán‐Sedano, José María Pedrajas, Pilar Llamas, Patricia Sigüenza, M.J. Jaras, Manuel Quintana‐Díaz, Carmen Fernández‐Capitán, Behnood Bikdeli, David Jiménez, Manuel Monréal, Dolores Adarraga, Jesús Aibar, Ciro Baeza, Aitor Ballaz, Raquel Barba, Á. Blanco-Molina, Enrique Ramón Botella, Juan Criado, Pablo Demelo‐Rodríguez, Díaz‐Brasero AM, de Ancos C, del Toro J, Farfán‐Sedano AI, Carmen Fernández‐Capitán, Ángeles Fidalgo, Katia Flores, Cristina Gabara, Francisco Galeano‐Valle, Olga Gavín‐Sebastián, Aída Gil‐Díaz, M.J. Jaras, Luis Jara‐Palomares, Ruth Jiménez Castuera, S. Láinez-Justo, Amaya Delgado Latorre, Ramón Lecumberri, Pilar Llamas, Lobo JL, Luciano López-Jiménez, Bruna Melo Coelho Loureiro, Olga Madridano, Mancebo‐Plaza AB, Martín del Pozo M, Manuel Monréal, Muñoz‐Rivas N, Núñez‐Fernández MJ, Olivera PE, Lucía Ordieres‐Ortega, Padín‐Paz EM, JM Pedrajas, Manuel Quintana‐Díaz, Mónica Ríos-Prego, Rodríguez‐Chiaradía DA, Pedro Ruiz‐Artacho, Patricia Sigüenza, Suriñach Jm, Javier Trujillo‐Santos, C Zamora, Eugenio Bucherini, Di Micco P, Egidio Imbalzano, Carmine Siniscalchi, Marijan Bosevski, Mirjana Stevanović, L Paz‐Rios, Ido Weinberg

2021Journal of Thrombosis and Haemostasis55 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineInternal medicineVirologyDiseaseInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesHeparin-Induced Thrombocytopenia and ThrombosisVenous Thromboembolism Diagnosis and Management
Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis | Litcius